We are live on ! Find out more
Ensign Peak Advisors

Ensign Peak Advisors Portfolio holdings

AUM $53.7B
1-Year Est. Return 29.47%
This Fund
S&P 500
This Quarter Est. Return
+11.03%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
AUM
$60.9B
AUM Growth
+$2.53B
Cap. Flow
-$2.05B
Cap. Flow %
-3.37%
Top 10 Hldgs %
34.77%
Holding
1,731
New
34
Increased
253
Reduced
1,344
Closed
34

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$163M
2
FOUR icon
Shift4
FOUR
+$127M
3
TMO icon
Thermo Fisher Scientific
TMO
+$126M
4
ELF icon
e.l.f. Beauty
ELF
+$94.4M
5
KKR icon
KKR & Co
KKR
+$84.6M

Sector Composition

Rank Sector Weight
1 Technology 33.11%
2 Financials 12.96%
3 Healthcare 11.29%
4 Communication Services 9.96%
5 Consumer Discretionary 9.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TWST icon
551
Twist Bioscience
TWST
$5.51B
$6.37M 0.01%
226,272
+61,000
+37% +$1.85M
PTC icon
552
PTC
PTC
$14.7B
$6.36M 0.01%
31,316
-13,400
-30% -$2.73M
AVR
553
Anteris Technologies
AVR
$795M
$6.34M 0.01%
1,408,245
-32,887
-2% -$129K
VRNA
554
DELISTED
Verona Pharma
VRNA
$6.28M 0.01%
58,863
-94,757
-62% -$9.89M
LH icon
555
Labcorp
LH
$25.8B
$6.17M 0.01%
21,490
-7,190
-25% -$1.93M
LDOS icon
556
Leidos
LDOS
$14.9B
$6.13M 0.01%
32,434
-13,190
-29% -$2.3M
CORT icon
557
Corcept Therapeutics
CORT
$10.1B
$6.1M 0.01%
73,414
-13,805
-16% -$999K
IFF icon
558
International Flavors & Fragrances
IFF
$20.2B
$6.08M 0.01%
98,858
-20,145
-17% -$1.38M
HLI icon
559
Houlihan Lokey
HLI
$10.2B
$6.01M 0.01%
29,256
-8,610
-23% -$1.69M
O icon
560
Realty Income
O
$61.3B
$5.9M 0.01%
97,134
-44,337
-31% -$2.58M
FOXA icon
561
Fox Class A
FOXA
$24.2B
$5.82M 0.01%
92,343
-43,140
-32% -$2.5M
SSNC icon
562
SS&C Technologies
SSNC
$18.8B
$5.78M 0.01%
65,077
-22,810
-26% -$1.97M
RAPP
563
Rapport Therapeutics
RAPP
$2.01B
$5.77M 0.01%
194,200
PHM icon
564
Pultegroup
PHM
$25.7B
$5.76M 0.01%
43,588
-18,935
-30% -$2.35M
UBS icon
565
UBS Group
UBS
$171B
$5.72M 0.01%
140,094
-63,950
-31% -$2.48M
TD icon
566
Toronto Dominion Bank
TD
$199B
$5.71M 0.01%
71,353
-32,700
-31% -$2.45M
FIVE icon
567
Five Below
FIVE
$11.5B
$5.68M 0.01%
36,691
-321,603
-90% -$45.5M
MTSR
568
DELISTED
Metsera Inc
MTSR
$5.62M 0.01%
107,318
IP icon
569
International Paper
IP
$23.3B
$5.61M 0.01%
120,986
-42,565
-26% -$2.08M
STE icon
570
Steris
STE
$22.4B
$5.58M 0.01%
22,556
-10,716
-32% -$2.56M
NUVL
571
DELISTED
Nuvalent
NUVL
$5.57M 0.01%
64,379
-30,461
-32% -$2.41M
BRBR icon
572
BellRing Brands
BRBR
$1.59B
$5.52M 0.01%
151,784
+67,492
+80% +$3.05M
NVR icon
573
NVR
NVR
$17.3B
$5.51M 0.01%
686
-560
-45% -$4.45M
CHRW icon
574
C.H. Robinson
CHRW
$20B
$5.51M 0.01%
41,592
-14,460
-26% -$1.7M
PPG icon
575
PPG Industries
PPG
$26.5B
$5.48M 0.01%
52,144
+16,195
+45% +$1.8M

Similar funds

Ensign Peak Advisors's Q3 2025 Portfolio in Review

As of Q3 2025, Ensign Peak Advisors held 1,731 positions worth $60.9B, up 4.3% from $58.4B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Ensign Peak Advisors withdrew a net $2.05B in Q3 2025, closing 34 positions and reducing 1,344 holdings. Its most notable exit was WNS Holdings, an estimated $34M position sold in full.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 31% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Ensign Peak Advisors opened a new position in Heartflow Inc worth $21.1M.

  • Ensign Peak Advisors's largest Q3 2025 buy was Heartflow Inc: 625,812 shares worth $21.1M.
  • Ensign Peak Advisors added most to Amazon in Q3 2025, an estimated $163M increase.
  • Ensign Peak Advisors's biggest Q3 2025 reduction was Eli Lilly, cutting an estimated $181M.
  • Ensign Peak Advisors fully exited WNS Holdings in Q3 2025, selling an estimated $34M.
  • Ensign Peak Advisors's ten largest holdings make up 35% of its $60.9B portfolio in Q3 2025.
  • Ensign Peak Advisors opened 34 new positions and closed 34 in Q3 2025.
  • Ensign Peak Advisors's portfolio value rose 4.3% quarter-over-quarter to $60.9B.

Based on Ensign Peak Advisors's 13F filing for Q3 2025, filed 13 Nov 2025.